Necroptosis Mediates Muscle Protein Degradation in a Cachexia Model of Weanling Pig with Lipopolysaccharide Challenge
International Journal of Molecular Sciences · 10 authors, 3 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This study used a lipopolysaccharide (LPS)-challenged weanling pig model to investigate muscle wasting in cachexia. The central result was that inhibiting the cell death process necroptosis with Nec-1 alleviated LPS-induced muscle inflammation and protein degradation.
Full summary
766 CHARS
This preclinical study used weanling pigs to model cachexia induced by LPS injection. Researchers measured plasma hormone markers, muscle morphology, and molecular pathways at various time points after LPS challenge. They found LPS triggered a systemic inflammatory response, activated the Akt/FOXO/UPS muscle protein degradation pathway, and upregulated necroptosis markers (RIP1, RIP3, MLKL) in muscle. Pretreatment with the necroptosis inhibitor Nec-1 reversed LPS-induced upregulation of necroptosis markers, attenuated muscle morphological damage, reduced inflammation, and alleviated the reduction in muscle protein content and key degradation gene expression. The implications suggest necroptosis is a potential target for treating muscle wasting in cachexia.